| Psychometric properties of the four-item morisky green levine medication adherence scale among atherosclerosis risk in communities (ARIC) study participants H Beyhaghi, BB Reeve, JE Rodgers, SC Stearns Value in Health 19 (8), 996-1001, 2016 | 92 | 2016 |
| Association of inpatient vs outpatient onset of ST-elevation myocardial infarction with treatment and clinical outcomes P Kaul, JJ Federspiel, X Dai, SC Stearns, SC Smith, M Yeung, ... Jama 312 (19), 1999-2007, 2014 | 57 | 2014 |
| Comparative cost-effectiveness of clinic, home, or ambulatory blood pressure measurement for hypertension diagnosis in US adults: a modeling study H Beyhaghi, AJ Viera Hypertension 73 (1), 121-131, 2019 | 56 | 2019 |
| Mild traumatic brain injury in the United States: demographics, brain imaging procedures, health-care utilization and costs V Pavlov, P Thompson-Leduc, L Zimmer, J Wen, J Shea, H Beyhaghi, ... Brain injury 33 (9), 1151-1157, 2019 | 42 | 2019 |
| Predictors of medication adherence in the elderly: the role of mental health JE Rodgers, EM Thudium, H Beyhaghi, CA Sueta, KA Alburikan, ... Medical Care Research and Review 75 (6), 746-761, 2018 | 27 | 2018 |
| Sexually transmitted infections in Tehran M Afrakhteh, H Beyhaghi, A Moradi, SJ Hosseini, A Mahdavi, S Giti, ... Journal of Family and Reproductive Health, 123-128, 2008 | 20 | 2008 |
| The prevalence of Chlamydia trachomatis in patients who remained symptomatic after completion of sexually transmitted infection treatment M Afrakhteh, A Mahdavi, H Beyhaghi, A Moradi, S Gity, S Zafargandi, ... Iranian journal of reproductive medicine 11 (4), 285, 2013 | 16 | 2013 |
| Cost-effectiveness of respiratory syncytial virus preventive interventions in children: a model comparison study X Li, D Hodgson, J Flaig, A Kieffer, WL Herring, H Beyhaghi, L Willem, ... Value in health 26 (4), 508-518, 2023 | 15 | 2023 |
| Symptom burden and life challenges reported by adult chordoma patients and their caregivers PH Song, H Beyhaghi, J Sommer, AV Bennett Quality of Life Research 26, 2237-2244, 2017 | 15 | 2017 |
| Limiting acute kidney injury progression in sepsis: study protocol and trial simulation L Molinari, F Heskia, S Peerapornratana, C Ronco, L Guzzi, S Toback, ... Critical Care Medicine 49 (10), 1706-1716, 2021 | 12 | 2021 |
| Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker MA Berdugo, NY Kirson, L Zimmer, H Beyhaghi, S Toback, LM Scarpati, ... Journal of Medical Economics 22 (12), 1281-1289, 2019 | 12 | 2019 |
| With established safe and effective use, protein vaccines offer another choice against COVID-19 AM Marchese, H Beyhaghi, WA Orenstein Vaccine 40 (46), 6567, 2022 | 11 | 2022 |
| The appropriate approach for adoption of clinical practice guidelines in the national health system, according to the experienced project in Iran national health system B Bikdeli, S Kermani, H Beyhaghi, F Kasraei, S Rajaei, E Chitsaz, ... Hakim Journal 13 (1), 49-57, 2010 | 8 | 2010 |
| Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United States S Earnshaw, H Beyhaghi, C McDade, M Purser, R Marriott, L Daane, ... Transfusion 61 (10), 2885-2897, 2021 | 7 | 2021 |
| Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting L Zimmer, C McDade, H Beyhaghi, M Purser, J Textoris, A Krause, ... Journal of neurotrauma 40 (7-8), 706-719, 2023 | 6 | 2023 |
| NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial AM Marchese, X Zhou, J Kinol, E Underwood, W Woo, A McGarry, ... Vaccine 41 (22), 3461-3466, 2023 | 4 | 2023 |
| Antihypertensive adherence and outcomes among community‐dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study JJ Federspiel, CA Sueta, AM Kucharska‐Newton, H Beyhaghi, L Zhou, ... Journal of Evaluation in Clinical Practice 24 (1), 48-55, 2018 | 4 | 2018 |
| The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review AM Marchese, M Rousculp, J Macbeth, H Beyhaghi, BT Seet, S Toback The Journal of Infectious Diseases, jiad519, 2023 | 2 | 2023 |
| Cost-effectiveness of nivolumab+ ipilimumab in first-line treatment of advanced melanoma: Analysis using 28-month overall survival from CheckMate 067 J Sabater, T Baker, V Paly, K Gupte-Singh, M Lorenzi, A Jeffers, ... Annals of Oncology 28, v396, 2017 | 2 | 2017 |
| STEMI Occurring in hospitalized patients is associated with less aggressive care and higher mortality than outpatient STEMI JJ Federspiel, X Dai, SC Stearns, SC Smith, P Kaul, M Yeung, ... Circulation 128 (suppl_22), A13054-A13054, 2013 | 2 | 2013 |
